Hylenex is an injectable enzyme used to help fluids and medications spread more easily through tissue under the skin. It has three FDA-approved uses: aiding subcutaneous rehydration, improving the absorption of other injected drugs, and enhancing certain imaging procedures. It’s also widely used off-label in cosmetic settings to dissolve hyaluronic acid dermal fillers.
How Hylenex Works
Your connective tissue contains a natural substance called hyaluronic acid, a thick, gel-like molecule that acts as a kind of cement between cells. Hylenex contains an enzyme (hyaluronidase) that temporarily breaks down this gel, reducing the tissue’s viscosity and making it more permeable. Once the hyaluronic acid is broken apart, fluids and medications injected under the skin can spread and absorb much more quickly than they otherwise would. The effect is temporary; your body naturally rebuilds the hyaluronic acid over time.
Hylenex is a recombinant human form of hyaluronidase, meaning it’s manufactured using human DNA technology rather than extracted from animal tissue. Older versions of hyaluronidase came from bovine or ovine sources and carried a small risk of allergic reactions because the proteins were foreign to the human body. The recombinant human version produces a purer preparation with lower allergic and immunologic risk.
Subcutaneous Rehydration
One of the primary uses for Hylenex is helping deliver fluids under the skin, a technique called hypodermoclysis. This is especially useful for patients who can’t receive fluids through an IV, such as elderly patients with fragile veins, young children, or people receiving palliative care at home. Without Hylenex, fluid injected under the skin absorbs slowly and pools uncomfortably at the injection site. With the enzyme, that fluid disperses into surrounding tissue and enters the bloodstream much faster. A single dose of 150 units facilitates absorption of 1,000 mL or more of fluid.
Boosting Absorption of Injected Drugs
When a medication is injected subcutaneously, it sometimes sits in a small pocket of tissue before gradually absorbing. Hylenex speeds up that process by loosening the tissue barrier. This is useful for drugs that need to reach the bloodstream quickly or that cause discomfort when concentrated in one spot. One important caveat: Hylenex is not given intravenously, because the enzyme is rapidly inactivated once it enters the bloodstream directly. It only works when injected into the tissue itself.
There are limits to which drugs Hylenex can be paired with. It should not be used to enhance absorption of dopamine or similar blood-pressure-raising medications. Certain drugs, including some seizure medications and sedatives, are chemically incompatible with hyaluronidase. And when combined with local anesthetics, Hylenex speeds up their onset but also shortens how long they last, because the anesthetic disperses and gets absorbed into the bloodstream more quickly.
Treating IV Extravasation
Extravasation happens when an IV medication accidentally leaks out of the vein and into the surrounding tissue. Depending on the drug, this can cause serious damage, from painful swelling to tissue death. Hylenex is used as a rescue treatment for certain types of extravasation, particularly with a class of chemotherapy drugs called vinca alkaloids (used in many cancer treatment regimens). By breaking down the connective tissue barrier, it helps the leaked drug disperse and absorb rather than concentrate in one area and cause injury. Treatment works best when started within one hour of the leak. It may also be considered for extravasation involving certain other chemotherapy agents.
Dissolving Dermal Fillers
Perhaps the most commonly searched reason people encounter Hylenex is its use in cosmetic dermatology. Though this is technically an off-label use in both the United States and the United Kingdom, Hylenex is widely used to dissolve hyaluronic acid-based dermal fillers. It breaks down the same molecule in filler that it breaks down in natural tissue, and many practitioners in the U.S. choose Hylenex specifically because it is the purest available formulation.
There are several reasons a provider might dissolve filler. The most straightforward is a poor aesthetic outcome: filler placed incorrectly, used in excess, or that has migrated over time. Hylenex can reverse these results without surgery. A more urgent reason is vascular occlusion, which occurs when filler accidentally compresses or enters a blood vessel and blocks blood flow. This is a time-sensitive emergency where rapid dissolution of the filler can prevent tissue damage.
Delayed-onset nodules are another indication. These lumps can appear weeks or months after a filler injection and may result from immune reactions, granulomas, or biofilm formation around the filler material. When the filler is hyaluronic acid-based, dissolving it with hyaluronidase removes the source of the problem, which is a significant advantage over non-dissolvable fillers.
Side Effects and Safety Considerations
The most common side effects are mild and local: redness and pain at the injection site. When used for subcutaneous fluid delivery, swelling (edema) at the infusion area is the most frequently reported issue. True allergic reactions, including hives or facial swelling, occur in fewer than 0.1% of patients. Severe anaphylactic-type reactions are rare and have been associated with specific injection routes rather than standard subcutaneous use.
Hylenex should not be injected into or near an infected or actively inflamed area, because loosening the tissue can allow a localized infection to spread. For the same reason, it’s not appropriate for reducing swelling from bites or stings. It also should never be applied directly to the eye.
One practical detail worth noting: if you take high doses of aspirin-type pain relievers, corticosteroids, estrogens, or antihistamines, your tissue may be partly resistant to hyaluronidase. This means a higher dose of the enzyme may be needed to achieve the same effect, which is relevant for both medical and cosmetic applications.